Fig. 7.
Improved overall survival as a result of combination therapy: immune checkpoint inhibitors and molecular targeted therapy. Modified from Sharma and Allison [18].
Improved overall survival as a result of combination therapy: immune checkpoint inhibitors and molecular targeted therapy. Modified from Sharma and Allison [18].